SCHEMBL8961523

SCHEMBL8961523

COc1cncc(C2CN3CCC2CC3)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9459080 0.99
SCHEMBL9458552 0.93 CHRM2 (0.42)
SCHEMBL9458966 0.85 CHRM2 (0.35)
SCHEMBL9459005 0.81 CHRM1 (0.44)
SCHEMBL9585060 0.80 CHRNA7 (0.41)
SCHEMBL9458898 0.80
SCHEMBL9710719 0.80
SCHEMBL9710931 0.80 CHRNA7 (0.41)
SCHEMBL9431645 0.79 CHRNA7 (0.45)
SCHEMBL9064276 0.79 CHRM2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0327155-A2 Pyrazines, pyrimidines and pyridazines, useful in the treatment of senile dementia MERCK SHARP & DOHME LTD. (GB) 1989-08-09 EP claimed
US-5574053-A Method for treating anxiety ELI LILLY AND COMPANY (US) 1996-11-12 US disclosed
US-5574029-A Method for treating anxiety ELI LILLY AND COMPANY (US) 1996-11-12 US disclosed
US-5260293-A Simulate central muscarinic acetlycholine receptors MERCK SHARP & DOHME LIMITED (GB) 1993-11-09 US disclosed
EP-0327155-A2 Pyrazines, pyrimidines and pyridazines, useful in the treatment of senile dementia MERCK SHARP & DOHME LTD. (GB) 1989-08-09 EP disclosed